Trending...
- Maryland: Urban Agriculture Advisory Committee Meeting Notice
- PUBLIC NOTICE UPDATE: Maryland Agencies to Treat Potomac River for Black Fly Control on June 30
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
BALTIMORE, Feb. 7, 2023 /PRNewswire/ -- CraniUS LLC, an R&D company focused on building groundbreaking diagnostics and treatments for neurosurgical patients with chronic brain disease, announces the appointment of Sharon Wolfington as Vice Chair to its Board of Directors.
Ms. Wolfington brings nearly four decades of medical device leadership amongst numerous global companies including Stryker, DJO Global, and Acumed. Most recently, Sharon served as the President and CEO at Acumed (a subsidiary of Colson Associates, a spinoff of the Marmon Group, a Berkshire Hathaway company). Under Sharon's leadership, Acumed expanded its portfolio into adjacent business segments that drove significant growth resulting in being recognized as one of 10 orthopedic companies to watch in 2022 by Bonezone.com. She currently serves on multiple boards of rapidly growing companies including recently serving on the Board of Directors at AdvaMed, a global advocacy organization standing for the highest ethical standards and patient access to safe, effective and innovative medical technologies.
More on Marylandian
"CraniUS is delighted to have Sharon joining our Board of Directors as Vice-Chair," said Michael Maglin, CEO of CraniUS. "Without question, she is one of the most respected MedTech leaders and a true innovator in the medical device space. Her experience in managing large organizations through hyper-growth intervals and consistently driving positive outcomes for patients is second-to-none."
Prior to leading Acumed, Ms. Wolfington spent over a decade working at Stryker as President of Performance Solutions and Vice President and General Manager of Stryker Trauma & Extremities. Ms. Wolfington attended Miami University, where she received her Liberal Arts degree, and Harvard Business School as part of the Advanced Management Program. "I am thrilled to join the CraniUS' Board of Directors and to help lead the company in building the world's first fully implantable, wireless medical device that enables chronic and direct delivery of medicine to the brain," says Sharon.
More on Marylandian
About CraniUS:
CraniUS' was recently voted the #1 Fastest-Rising Tech Company in Baltimore by Technical.ly. Its stated mission is to invent and engineer world-class technology to define the future of diagnostics and treatments for patients with chronic brain disease. Its flagship device is being specifically developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional therapeutic treatments of brain disease ineffective. CraniUS utilizes a novel pump design and wireless charging technology to enable long-term and direct medicine administration via CED (convection-enhanced delivery), an effective method of medicine delivery first introduced by the National Institute of Health (NIH). CraniUS was co-founded in May 2021 in Baltimore, MD, by Dr. Chad Gordon, the pioneer behind the emerging field known as "Neuroplastic and Reconstructive Surgery," and CraniUS Chief Technology Officer, Deborah Weidman.
SOURCE CraniUS
Ms. Wolfington brings nearly four decades of medical device leadership amongst numerous global companies including Stryker, DJO Global, and Acumed. Most recently, Sharon served as the President and CEO at Acumed (a subsidiary of Colson Associates, a spinoff of the Marmon Group, a Berkshire Hathaway company). Under Sharon's leadership, Acumed expanded its portfolio into adjacent business segments that drove significant growth resulting in being recognized as one of 10 orthopedic companies to watch in 2022 by Bonezone.com. She currently serves on multiple boards of rapidly growing companies including recently serving on the Board of Directors at AdvaMed, a global advocacy organization standing for the highest ethical standards and patient access to safe, effective and innovative medical technologies.
More on Marylandian
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
- New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
"CraniUS is delighted to have Sharon joining our Board of Directors as Vice-Chair," said Michael Maglin, CEO of CraniUS. "Without question, she is one of the most respected MedTech leaders and a true innovator in the medical device space. Her experience in managing large organizations through hyper-growth intervals and consistently driving positive outcomes for patients is second-to-none."
Prior to leading Acumed, Ms. Wolfington spent over a decade working at Stryker as President of Performance Solutions and Vice President and General Manager of Stryker Trauma & Extremities. Ms. Wolfington attended Miami University, where she received her Liberal Arts degree, and Harvard Business School as part of the Advanced Management Program. "I am thrilled to join the CraniUS' Board of Directors and to help lead the company in building the world's first fully implantable, wireless medical device that enables chronic and direct delivery of medicine to the brain," says Sharon.
More on Marylandian
- The Herbal Care, Led by Markel Bababekov, Becomes a Top Dispensary in NYC's Upper East Side
- Digital Watchdog Launches New myDW Cloud Services
- Stan Fitzgerald Appointed Acting Press Secretary for Veterans for America First VFAF Georgia State Chapter
- Drone Light Shows Emerge as the New Standard in Live Event Entertainment
- Lore Link is Here to Help Organize Your Game
About CraniUS:
CraniUS' was recently voted the #1 Fastest-Rising Tech Company in Baltimore by Technical.ly. Its stated mission is to invent and engineer world-class technology to define the future of diagnostics and treatments for patients with chronic brain disease. Its flagship device is being specifically developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional therapeutic treatments of brain disease ineffective. CraniUS utilizes a novel pump design and wireless charging technology to enable long-term and direct medicine administration via CED (convection-enhanced delivery), an effective method of medicine delivery first introduced by the National Institute of Health (NIH). CraniUS was co-founded in May 2021 in Baltimore, MD, by Dr. Chad Gordon, the pioneer behind the emerging field known as "Neuroplastic and Reconstructive Surgery," and CraniUS Chief Technology Officer, Deborah Weidman.
SOURCE CraniUS
Filed Under: Business
0 Comments
Latest on Marylandian
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- YYNOT Brings High-Energy RUSH Tribute to the Weinberg Center this September
- Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
- Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
- Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
- AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- PUBLIC NOTICE UPDATE: Maryland Agencies to Treat Potomac River for Black Fly Control on June 30
- Maryland: Urban Agriculture Advisory Committee Meeting Notice
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- Psychologist-Turned-Hermeticist Releases Modern Guide to the Seven Hermetic Principles
- Winners Announced for Asia Pacific Business Awards 2024-2025
- Hamvay-Lang and Lampone.hu Join Forces with AIMarketingugynokseg.hu to Elevate Hungarian Lifestyle Brands on the Global Stage